Today's story
AstraZeneca and Oracle begin AI project to speed trial recruitment
AstraZeneca and Oracle signed a non-binding AI deal on Oct. 20, 2026; first program with M42 targets uncontrolled hypertension for trial recruitment in Abu Dhabi.
Health · 9 sources · Oct 20, 2026Read it
The journal
Open the journal →The conversation starts in the journal — be the first to post.
About AstraZeneca
AstraZeneca plc (AZ) is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
Everything about AstraZeneca →- Country
- United Kingdom, Sweden
- Headquarters
- Cambridge, Cambridge Biomedical Campus
- Inception
- 1913
- Website
- http://www.astrazeneca.com/
